BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6573207)

  • 1. Cancer and secondary leukemia.
    Rosner F
    Bull Cancer; 1983; 70(1):55-60. PubMed ID: 6573207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myelogenous leukaemia following cytotoxic therapy: five cases and a review.
    Smith AG; Prentice AG; Lucie NP; Browning JD; Dagg JH; Rowan RM
    Q J Med; 1982; 51(202):227-40. PubMed ID: 6955825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.
    Meadows AT; Obringer AC; Marrero O; Oberlin O; Robison L; Fossati-Bellani F; Green D; Voƻte PA; Morris-Jones P; Greenberg M
    Med Pediatr Oncol; 1989; 17(6):477-84. PubMed ID: 2586362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary myelodysplastic syndromes and leukaemias.
    Levine EG; Bloomfield CD
    Clin Haematol; 1986 Nov; 15(4):1037-80. PubMed ID: 3552347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study.
    Glicksman AS; Pajak TF; Gottlieb A; Nissen N; Stutzman L; Cooper MR
    Cancer Treat Rep; 1982 Apr; 66(4):1035-44. PubMed ID: 6951632
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma.
    Greene MH; Young RC; Merrill JM; DeVita VT
    Cancer Res; 1983 Apr; 43(4):1891-8. PubMed ID: 6572558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second neoplasms in Hodgkin's disease: current controversies.
    Zarrabi MH; Rosner F
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second malignancy complicating Hodgkin's disease.
    Tawil E; Mercier JP
    J Can Assoc Radiol; 1983 Jun; 34(2):108-13. PubMed ID: 6688422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute leukemias and solid tumors in the course of Hodgkin disease].
    Jacquillat C; Auclerc G; Weil M; Auclerc MF; Maral J
    Bull Cancer; 1983; 70(1):61-6. PubMed ID: 6687694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute myeloid leukemia during Hodgkin's disease].
    Dziewulska-Bokiniec A; Jassem J
    Acta Haematol Pol; 1979; 10(2):137-40. PubMed ID: 289273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease.
    Henry-Amar M
    J Natl Cancer Inst; 1983 Nov; 71(5):911-6. PubMed ID: 6580491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup.
    Coltman CA; Dixon DO
    Cancer Treat Rep; 1982 Apr; 66(4):1023-33. PubMed ID: 7074630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary myelodysplastic syndromes and leukemias.
    Giles FJ; Koeffler HP
    Curr Opin Hematol; 1994 Jul; 1(4):256-60. PubMed ID: 9371291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute leukemia following prolonged cytotoxic agent therapy.
    Casciato DA; Scott JL
    Medicine (Baltimore); 1979 Jan; 58(1):32-47. PubMed ID: 105227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute myelogenous leukemia 11 years after successful treatment of Hodgkin's disease. A contribution to the problem of secondary tumors].
    Ritter J; Oehme J
    Med Klin; 1978 Sep; 73(39):1360-2. PubMed ID: 279796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemia and other cancers after radiotherapy and chemotherapy for Hodgkin's disease.
    Boivin JF; Hutchison GB
    J Natl Cancer Inst; 1981 Oct; 67(4):751-60. PubMed ID: 6944544
    [No Abstract]   [Full Text] [Related]  

  • 19. Myelodysplastic syndrome and acute leukaemia following treatment of soft tissue sarcoma.
    de Graeff A; Vendrik CP; Pinedo HM
    Neth J Med; 1989 Jun; 34(5-6):251-7. PubMed ID: 2671758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for second malignant neoplasms: report from the Late Effects Study Group.
    Meadows AT
    Bull Cancer; 1988; 75(1):125-30. PubMed ID: 3359054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.